Join the Generalized Pustular Psoriasis group to help and get support from people like you.
Generalized Pustular Psoriasis News
Related terms: GPP
AMD Risk Increases With Psoriasis
FRIDAY, Sept. 19, 2025 – Psoriasis is associated with an increased risk for age-related macular degeneration (AMD), with increased risks seen for exudative and nonexudative AMD, according to a study...
Ozempic, Zepbound Offer Unexpected Benefits For Psoriasis Patients
THURSDAY, Sept. 18, 2025 — People with psoriasis might receive unexpected benefits from cutting-edge weight loss drugs like Ozempic and Zepbound, a new study says. Psoriasis patients taking GLP-1 d...
Psoriasis 101: Causes, Symptoms and Treatments, Explained
MONDAY, July 7, 2025 — Psoriasis is a chronic autoimmune condition that mainly affects the skin. When you have psoriasis, your immune system sends signals to your skin cells to grow too fast. N...
Central Adiposity Measures Associated With Psoriasis Risk
TUESDAY, June 3, 2025 – Central adiposity measures are strongly associated with psoriasis risk, with a stronger association in women, according to a research letter published online May 27 in the...
Flares Occur Frequently in Generalized Pustular Psoriasis
WEDNESDAY, April 16, 2025 – Patients with generalized pustular psoriasis (GPP) experience frequent flares, and treatment alterations of off-label agents are frequently observed, according to a study...
High Ultraprocessed Food Intake Linked to Active Psoriasis
TUESDAY, Dec. 3, 2024 – High ultraprocessed food (UPF) intake is associated with active psoriasis, according to a research letter published online Nov. 27 in JAMA Dermatology. Laetitia Penso, Ph.D.,...
Home-Based Phototherapy as Effective as Office-Based for Psoriasis
MONDAY, Sept. 30, 2024 – For plaque or guttate psoriasis, home-based narrowband ultraviolet B phototherapy is as effective as office-based phototherapy, according to a study published online Sept....
FDA Approves Expanded Generalized Pustular Psoriasis Indications for Spevigo
Ingelheim, Germany, March 19, 2024 – Boehringer Ingelheim today announced that the US Food and Drug Administration (FDA) has approved Spevigo (spesolimab-sbzo) injection for the treatment of...